Back |
home / stock / ipha / ipha message board
Subject | By | Source | When |
---|---|---|---|
$IPHA: I got stopped out at 4.40 | makinezmoney | investorshub | 09/02/2021 4:07:32 PM |
Adding here. Looks primed to test the premarket | Beamer00 | investorshub | 09/02/2021 2:53:29 PM |
$IPHA: Know what your comfort level is...... | makinezmoney | investorshub | 09/02/2021 2:37:07 PM |
Damn i got in at 5.35 | adamski | investorshub | 09/02/2021 2:34:51 PM |
$IPHA: Cmonnnnnnnnnnnnn upside halter........ | makinezmoney | investorshub | 09/02/2021 2:11:23 PM |
$IPHA: Id like to see that $10 PreMarket | makinezmoney | investorshub | 09/02/2021 1:39:57 PM |
Huge gapgetting filled a bit | adamski | investorshub | 09/02/2021 1:37:46 PM |
$IPHA: $HUGE$ OPEN buys here..... Almost 1.2Million right there | makinezmoney | investorshub | 09/02/2021 1:32:19 PM |
$IPHA: Hope this is the next $SAVA or $ICPT | makinezmoney | investorshub | 09/02/2021 1:26:35 PM |
$IPHA: 3Milly traded already........ | makinezmoney | investorshub | 09/02/2021 1:01:30 PM |
$IPHA: Now 5.50 | makinezmoney | investorshub | 09/02/2021 12:33:18 PM |
$IPHA: Presentation DETAILS today. | makinezmoney | investorshub | 09/02/2021 12:30:21 PM |
$IPHA: Don't mind a move back to $8..... | makinezmoney | investorshub | 09/02/2021 12:27:48 PM |
News, Short Squeeze, Breakout and More Instantly...
Regulatory News: Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities ( Autorité des Marchés Financiers , or “ AMF ”) General Regulation, Innate Pharma SA (Euronext Pari...
SAR443579/IPH6101, ANKET ® platform lead asset, is a first-in-class NKp46/CD16-based NK cell engager targeting CD123 from a joint research collaboration between Innate Pharma and Sanofi, under development by Sanofi in R/R AML, B-ALL and HR-MDS SAR443579/IPH6101 continues ...
In heavily pretreated patients with mycosis fungoides, treatment with lacutamab results in meaningful anti-tumor activity regardless of baseline KIR3DL2 expression level. Lacutamab was well-tolerated with a safety profile consistent with prior studies. Innate will host a virtual KOL...